Egetis Therapeutics AB (publ)
STO:EGTX

Watchlist Manager
Egetis Therapeutics AB (publ) Logo
Egetis Therapeutics AB (publ)
STO:EGTX
Watchlist
Price: 6.65 SEK 0.91%
Market Cap: 2.4B SEK
Have any thoughts about
Egetis Therapeutics AB (publ)?
Write Note

EV/OCF
Enterprise Value to OCF

-9.3
Current
-8.9
Median
5.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-9.3
=
Enterprise Value
2.3B SEK
/
Operating Cash Flow
-246.6m SEK
All Countries
Close
 
SE
Egetis Therapeutics AB (publ)
STO:EGTX
Average EV/OCF: 22.1
Negative Multiple: -9.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 741.6
US
Abbvie Inc
NYSE:ABBV
22.4
US
Amgen Inc
NASDAQ:AMGN
26.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.7
AU
CSL Ltd
ASX:CSL
34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More